EXPLORING THE THERAPEUTIC POTENTIAL OF RESVERATROL AND QUERCETIN IN GASTROINTESTINAL CANCER: A NUTRITIONAL INTERVENTION APPROACH

Authors

  • Sidra Noor
  • Osama Basharat
  • Aaima Farooq
  • Anam Tariq
  • Saba Siddiqui
  • Mahreen Faqeer Hussain
  • Mahnoor
  • Amsa Fatima

DOI:

https://doi.org/10.53555/s7cn9t15

Keywords:

AgNORs, Beta-Catenin, Biomarkers, Cellular Health, Crypt Abnormalities, Goblet Cells, M30 Tissue Level, Mucosal Stratification, Natural Compounds, Nuclear Polarity, Nucleus Polymorphism, Quercetin, Resveratrol, Therapeutic Interventions.

Abstract

This study examines the impacts of resveratrol and quercetin, both individually and in combination, on different cellular irregularities and biomarkers in a carefully regulated experimental paradigm. Analyzed criteria included nucleus polymorphism, mucosal stratification, loss of nuclear polarity, decreased goblet cells, crypt abnormalities, M30 tissue level, AgNORs in the core, and beta-catenin expression. The results indicate substantial differences across the groups regarding nucleus variability, mucosal categorization, loss of nuclear polarity, decreased goblet cells, and crypt abnormalities (p=0.001). This suggests that the treatments have resulted in various degrees of cellular response. Furthermore, notable disparities were noted in the M30 tissue level, AgNORs in core, and beta-catenin expression, underscoring differential modifications in cellular processes and biomarkers associated with various therapies (p<0.05). More precisely, the concurrent use of resveratrol and quercetin resulted in decreased beta-catenin expression in comparison to the other experimental groups. These findings highlight the capability of resveratrol and quercetin, both separately and together, to regulate indicators of cellular health. This has implications for therapeutic treatments aimed at addressing cellular irregularities and associated diseases. Additional research is necessary to clarify the underlying mechanisms and improve therapeutic approaches using these natural chemicals.

Author Biographies

  • Sidra Noor

    Visiting Lecturer, Khawaja Fareed University of Engineering and Information Technology, Rahim Yar Khan, Pakistan 

  • Osama Basharat

    MPhil Student, University Institute of Diet & Nutritional Sciences, The University of Lahore, Pakistan 

  • Aaima Farooq

    Dietitian and Nutritionist, Job Leading Nutrition Department, Chaudhary Muhammad Akram Teaching and Research Hospital, Lahore, Pakistan 

  • Anam Tariq

    Bachelor Student, University of Veterinary and Animal Sciences, Lahore, Pakistan 

  • Saba Siddiqui

    MPhil Student, Kinnaird College for Women University, Lahore, Pakistan 

  • Mahreen Faqeer Hussain

    MPhil Student, University Institute of Diet & Nutritional Sciences, The University of Lahore, Pakistan 

  • Mahnoor

    Nutritionist, Lady Willingdon Hospital, Lahore, Pakistan 

  • Amsa Fatima

    Lecturer, University Institute of Diet & Nutritional Sciences, The University of Lahore, Pakistan 

References

Blanquer-Rosselló, M. M., Oliver, J., Valle, A., & Roca, P. (2013). Effect of xanthohumol and 8-prenylnaringenin on MCF-7 breast cancer cells oxidative stress and mitochondrial complexes expression. Journal of Cellular Biochemistry, 114(12), 2785-2794.

Buhrmann, C., Yazdi, M., Popper, B., Shayan, P., Goel, A., Aggarwal, B. B., et al. (2018). Resveratrol chemosensitizes TNF-β-induced survival of 5-FU-treated colorectal cancer cells. Nutrients, 10(7), 888.

Choudhari, A. S., Mandave, P. C., Deshpande, M., Ranjekar, P., & Prakash, O. (2020). Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Frontiers in Pharmacology, 10, 497776.

Fouad, M. A., Agha, A. M., Merzabani, M. M., & Shouman, S. A. (2013). Resveratrol inhibits proliferation, angiogenesis, and induces apoptosis in colon cancer cells: Calorie restriction is the force to the cytotoxicity. Human & Experimental Toxicology, 32(10), 1067-1080.

George, B. P., Chandran, R., & Abrahamse, H. (2021). Role of phytochemicals in cancer chemoprevention: Insights. Antioxidants, 10(9), 1455.

Hammoud, S. S., Cairns, B. R., & Jones, D. A. (2013). Epigenetic regulation of colon cancer and intestinal stem cells. Current Opinion in Cell Biology, 25(2), 177-183.

Hanahan, D. (2022). Hallmarks of cancer: new dimensions. Cancer Discovery, 12(1), 31-46.

Hermann, P. C., Huber, S. L., Herrler, T., et al. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 1(3), 313-323.

Hosseini, A., & Ghorbani, A. (2015). Cancer therapy with phytochemicals: Evidence from clinical studies. Avicenna Journal of Phytomedicine, 5, 84-97.

Kabirai, A., Chahar, A., Chahar, N., & Gupta, J. (2020). Chemical carcinogenesis: A brief review on mechanism & metabolism. Journal of Oral Medicine, Oral Surgery, Oral Pathology, and Oral Radiology, 6, 120-124.

Downloads

Published

2024-09-08

How to Cite

Sidra Noor, Osama Basharat, Aaima Farooq, Anam Tariq, Saba Siddiqui, Mahreen Faqeer Hussain, Mahnoor, & Amsa Fatima. (2024). EXPLORING THE THERAPEUTIC POTENTIAL OF RESVERATROL AND QUERCETIN IN GASTROINTESTINAL CANCER: A NUTRITIONAL INTERVENTION APPROACH. Journal of Population Therapeutics and Clinical Pharmacology, 31(9), 3116-3129. https://doi.org/10.53555/s7cn9t15
More Citation Formats

Issue

Section

Articles

How to Cite

Sidra Noor, Osama Basharat, Aaima Farooq, Anam Tariq, Saba Siddiqui, Mahreen Faqeer Hussain, Mahnoor, & Amsa Fatima. (2024). EXPLORING THE THERAPEUTIC POTENTIAL OF RESVERATROL AND QUERCETIN IN GASTROINTESTINAL CANCER: A NUTRITIONAL INTERVENTION APPROACH. Journal of Population Therapeutics and Clinical Pharmacology, 31(9), 3116-3129. https://doi.org/10.53555/s7cn9t15

Most read articles by the same author(s)